How does a large diverse pharmaceutical company go about ensuring brand protection and integrity of their supply chains? What are some of the strategies for prescription drugs versus medical devices? How do you measure your success in ensuring brand protection? Counterfeit medicine has been a great headache for the pharmaceutical industry. Technological innovation has somewhat stemmed the problem, but how can we stop them? John DiPalo, CTO at Acsis, Inc., joins Reid Graves from Merck and his panel of industry leaders to tackle the problem with serialization. To listen to the PodCast through 20/20 Pharma, click here.
Download PDF Version